Edgar Snyder & Associates®
A Law Firm Representing Injured People
Call Us Toll Free 24/7
Published on Apr 17, 2006 by Edgar Snyder

Estrogen Plus Progestin Risks

Sad Woman

Attempting to combat the risk of endometrial cancer in postmenopausal women taking estrogen, doctors added progestin to hormone replacement therapies. However, recent evidence shows that this combination of hormones has its own set of risks.

Recently, two reports from the Women’s Health Initiative, a government-sponsored study of postmenopausal women, describes the safety difference between estrogen only and estrogen plus progestin. When comparing the two, long-term estrogen use is less risky than long-term estrogen plus progestin use.

Some findings to consider:

  • Breast cancer risk begins to rise after three to four years of estrogen plus progestin use.
  • Estrogen users are about 50% more likely to get blood clots than non-users.
  • Estrogen plus progestin users are twice as likely to get blood clots as non-users.

These findings have fueled the Food and Drug Administration (FDA) to advise women to consider taking the lowest does of estrogen and progestin allowed for symptom relief.

For more information about dangerous drugs, visit our Dangerous Drug and Recall Legal Center.

Drug litigation may involve co-counsel

Source: “Estrogen and progestin under increased scrutiny.” By Rita Rubin. USA Today. April 13, 2006.
Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
Briefly describe your injuries

Recent News

Sep 26, 2016
Gear Up, Cool Down, and Stay Safe While Riding This Fall
Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers
Sep 16, 2016
Smartphone Apps for Drivers
Sep 16, 2016
New CDC Tool Will Help Keep Traveling Workers Safe